医学
怀孕
子痫前期
产科
前瞻性队列研究
妊娠期
胎龄
妇科
内科学
遗传学
生物
作者
Antonio Brucato,Andrea Doria,Micol Frassi,G. Castellino,Franco Franceschini,D Faden,M. P. Pisoni,Laura Solerte,Marina Muscarà,Andrea Lojacono,Mario Motta,Ilaria Cavazzana,Anna Ghirardello,F. Vescovi,Valeria Tombini,Rolando Cimaz,Pier Franca Gambari,Pier Luigi Meroni,B Canesi,Anǵela Tincani
出处
期刊:Lupus
[SAGE Publishing]
日期:2002-11-01
卷期号:11 (11): 716-721
被引量:155
标识
DOI:10.1191/0961203302lu252oa
摘要
Anti-Ro/SSA antibodies are associated with neonatal lupus but are also considered a possible cause for unexplained pregnancy loss and adverse pregnancy outcome. In a large multicentres cohort study we have prospectively followed 100 anti-Ro/SSA positive women (53 systemic lupus erythematosus (SLE)) during their 122 pregnancies and 107 anti-Ro/SSA negative women (58 SLE) (140 pregnancies). Anti-Ro/SSA antibodies were tested by immunoblot and counterimunoelectrophoresis. Mean gestational age at delivery (38 vs 37.9 weeks), prevalence of pregnancy loss (9.9 vs 18.6%), preterm birth (21.3 vs 13.9%), cesarean sections (49.2 vs 53.4%), premature rupture of membranes (4.9 vs 8.1%), preeclampsia (6.6 vs 8%), intrauterine growth retardation (0 vs 2.3%)and newborns small for gestational age (11.5 vs 5.8%) were similar in anti-Ro/SSA positive and negative SLE mothers; findings were similar in non-SLE women. Two cases of congenital heart block were observed out of 100 anti-Ro/SSA positive women. In conclusion, anti-Ro/SSA antibodies are responsible for congenital heart block but do not affect other pregnancy outcomes, both in SLE and in non-SLE women. The general outcome of these pregnancies is now very good, ifprospectively followed by multidisciplinary teams with ample experience in this field.
科研通智能强力驱动
Strongly Powered by AbleSci AI